Drug Shortage Report for DILANTIN

Last updated on 2025-11-04 History
Report ID 269465
Drug Identification Number 00022780
Brand name DILANTIN
Common or Proper name PHENYTOIN SODIUM
Company Name BGP PHARMA ULC
Market Status MARKETED
Active Ingredient(s) PHENYTOIN SODIUM
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 1x100, 1x1000
ATC code N03AB
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-11-18
Actual start date
Estimated end date 2025-12-09
Actual end date
Shortage status Anticipated shortage
Updated date 2025-11-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2025-11-04 French Compare
v9 2025-11-04 English Compare
v8 2025-10-28 French Compare
v7 2025-10-28 English Compare
v6 2025-10-28 French Compare
v5 2025-10-28 English Compare
v4 2025-10-20 French Compare
v3 2025-10-20 English Compare
v2 2025-10-15 French Compare
v1 2025-10-15 English Compare

Showing 1 to 10 of 10